Antiparkinsonian efficacy of a novel transdermal delivery system for (+)-PHNO in MPTP-treated squirrel monkeys.
We examined the ability of the antiparkinsonian agent (+)-4-propyl-9-hydroxynaphthoxazine (PHNO) to enter the systemic circulation in therapeutic concentrations after continuous transdermal absorption in squirrel monkeys rendered parkinsonian by MPTP. Direct subcutaneous administration of (+)-PHNO i...
Main Authors: | Rupniak, N, Tye, S, Jennings, C, Loper, A, Bondi, J, Hichens, M, Hand, E, Iversen, S, Stahl, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1989
|
Similar Items
-
Therapeutic efficacy of a novel transdermal delivery system for (+)-PHNO in parkinsonian squirrel monkeys.
by: Rupniak, N, et al.
Published: (1989) -
(+)-PHNO: a new anti-parkinsonian agent which does not induce chorea in MPTP-treated squirrel monkeys.
by: Rupniak, N, et al.
Published: (1990) -
Characterisation of dyskinesias induced by L-dopa in MPTP-treated squirrel monkeys.
by: Boyce, S, et al.
Published: (1990) -
DIFFERENTIAL-EFFECTS OF D-1 AND D-2 DOPAMINE AGONISTS IN MPTP-TREATED SQUIRREL-MONKEYS
by: Boyce, S, et al.
Published: (1990) -
NB-355: a novel prodrug for L-DOPA with reduced risk for peak-dose dyskinesias in MPTP-treated squirrel monkeys.
by: Tye, S, et al.
Published: (1989)